RPL22 and neoplasm: One of these frameshift mutations, shared by two sync 11 tumours, was in RPL22, a gene that was recently reported to be frequently mutated in SCRC.18 This mutation was found altogether in 5 out of 47 tumours (11%), all of which were MSI.